Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Long-Term Capital Lease Obligation : ¥6 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Jincheng Pharmaceutical Group Co Long-Term Capital Lease Obligation?

Shandong Jincheng Pharmaceutical Group Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥6 Mil.

Shandong Jincheng Pharmaceutical Group Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2024 (¥3 Mil) to Dec. 2024 (¥7 Mil) but then declined from Dec. 2024 (¥7 Mil) to Mar. 2025 (¥6 Mil).

Shandong Jincheng Pharmaceutical Group Co's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (¥2 Mil) to Dec. 2023 (¥3 Mil) and increased from Dec. 2023 (¥3 Mil) to Dec. 2024 (¥7 Mil).

Shandong Jincheng Pharmaceutical Group Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shandong Jincheng Pharmaceutical Group Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Jincheng Pharmaceutical Group Co Long-Term Capital Lease Obligation Chart

Shandong Jincheng Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

63.23

63.52

2.02

3.46

6.88

Shandong Jincheng Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															4.53	3.60	3.34	6.88	6.03

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shandong Jincheng Pharmaceutical Group Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shandong Jincheng Pharmaceutical Group Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Jincheng Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Shandong Jincheng Pharmaceutical Group Co Ltd (SZSE:300233) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 1 Shuangshan Road, Zichuan Economic Development Zone, Shandong, Zibo, CHN, 255100

Website

http://www.jinchengpharm.com

Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.

Executives

Yang Xiu Liang	Executives
Zhang Xue Bo	Director
Zheng Geng Xiu	Director
Zhao Ye Qing	Director
Sun Rui Mei	Executives
Cui Xi Li	Executives
Zhao Hong Fu	Director
Fu Miao Qing	Executives
Zhu Xiao Gang	Directors, executives
Li Jia Quan	Directors, executives
Guo Fang Shui	Supervisors
Chou Qiang	Securities Affairs Representative

Shandong Jincheng Pharmaceutical Group Co Headlines

No Headlines